Compare KNTK & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KNTK | BLLN |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.6B |
| IPO Year | 2017 | 2025 |
| Metric | KNTK | BLLN |
|---|---|---|
| Price | $56.13 | $106.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 8 |
| Target Price | $58.75 | ★ $129.00 |
| AVG Volume (30 Days) | ★ 1.1M | 481.4K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | ★ 5.93% | N/A |
| EPS Growth | ★ 157.84 | 103.40 |
| EPS | ★ 0.61 | 0.48 |
| Revenue | $160,617,000.00 | ★ $305,112,000.00 |
| Revenue This Year | $20.63 | $49.05 |
| Revenue Next Year | $16.59 | $26.16 |
| P/E Ratio | ★ $89.90 | $219.77 |
| Revenue Growth | 8.23 | ★ 99.97 |
| 52 Week Low | $31.33 | $61.96 |
| 52 Week High | $56.92 | $150.44 |
| Indicator | KNTK | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 54.37 |
| Support Level | $53.14 | $89.26 |
| Resistance Level | $56.30 | $108.50 |
| Average True Range (ATR) | 1.55 | 6.28 |
| MACD | 0.19 | 0.77 |
| Stochastic Oscillator | 93.33 | 74.12 |
Kinetik Holdings Inc is a midstream operator that provides comprehensive gathering, transportation, compression, processing and treating services. Its activities also include NGL stabilization and transportation, produced water gathering and disposal, and crude oil gathering, stabilization, storage, and transportation. The company operates in two reportable segments: i) The Midstream Logistics segment operates under three service offerings: 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. ii) The Pipeline Transportation segment consists of two EMI Pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.